ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
67.151,27
0,11%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. GH Research PLC (GHRS)

  7. GH Research PLC (GHRS) News

GHRS

GH Research (GHRS)

GH Research PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GHRS
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202423h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
03/05/202413h00GlobeNewswire Inc.GH Research Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:GHRSGH Research PLC
07/03/202413h24Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:GHRSGH Research PLC
29/02/202413h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
29/02/202413h00GlobeNewswire Inc.GH Research Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:GHRSGH Research PLC
16/02/202422h57Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GHRSGH Research PLC
18/01/202422h37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
18/01/202422h30GlobeNewswire Inc.GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant DepressionNASDAQ:GHRSGH Research PLC
05/01/202413h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
13/11/202322h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
09/11/202323h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
09/11/202322h45GlobeNewswire Inc.GH Research Reports Third Quarter Financial Results and Provides Business UpdatesNASDAQ:GHRSGH Research PLC
06/10/202313h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
29/09/202322h45GlobeNewswire Inc.GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant DepressionNASDAQ:GHRSGH Research PLC
20/09/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
01/09/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
23/08/202313h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
23/08/202313h00GlobeNewswire Inc.GH Research Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:GHRSGH Research PLC
19/07/202322h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GHRSGH Research PLC
21/06/202322h31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GHRSGH Research PLC
02/06/202322h41Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:GHRSGH Research PLC
25/05/202313h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GHRSGH Research PLC
11/05/202313h42Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GHRSGH Research PLC
11/05/202313h30GlobeNewswire Inc.GH Research Reports First Quarter 2023 Financial Results and Provides Business HighlightsNASDAQ:GHRSGH Research PLC
30/03/202323h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GHRSGH Research PLC
20/03/202311h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GHRSGH Research PLC
13/03/202312h19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GHRSGH Research PLC
09/03/202322h57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GHRSGH Research PLC
09/03/202322h49Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:GHRSGH Research PLC
09/03/202313h09Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:GHRSGH Research PLC
 Showing the most relevant articles for your search:NASDAQ:GHRS

Kürzlich von Ihnen besucht

LSE
0KHQ
Scandinavian Private Equ...
LSE
47TW
Res Mtg 13 Nt36
DGFX
RBTC
Revain
USOTC
SHALF
Shangri La Asia (PK)
BIT
P22413
NLBNPIT22413 20991231 30...
ASX
GHCNA
LSE
AC46
Citi Fun 33
BIT
P20HG3
NLBNPIT20HG3 20351221 0....
BITMOT
791109
Cs Tf 1,5% Ap26 Eur
BIT
F14382
Vontobel Financial Produ...
BIT
Q00289
Leonteq Securities
EU
3799T
3799T
BIT
UB03RT
UniCredit Bank
BIT
UV8CP6
UniCredit Bank
EU
NL0015001AM2
Netherlands Domestic bon...
NASDAQ
FPPGRX
Inflation Hedge Portfoli...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten